Torrent Pharmaceuticals has reported result for second quarter ended September 30, 2025 (Q2FY26).
The company has reported 29.78% jump in its net profit at Rs 597 crore for the quarter ended September 30, 2025 as compared to Rs 460 crore for the same quarter in the previous year. The total income of the company increased by 12.69% at Rs 2,735 crore for Q2FY26 as compared to Rs 2,427 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 30.46% rise in its net profit at Rs 591 crore for Q2FY26 as compared to Rs 453 crore for the same quarter in the previous year. The total income of the company increased by 13.99% at Rs 3,275 crore for Q2FY26 as compared to Rs 2,873 crore for the corresponding quarter previous year.
